- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
First Helium
Purpose Bitcoin ETF
Soma Gold Corp.
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Biologix Creates Medical Advisory Board, Appoints Dr. Craig Ziering as Chairman
Biologix Hair Inc (OTCQB:BLGX, OTCBB:BLGX) announced that it has created a Medical Advisory Board and has appointed past president of the American Osteopathic College of Dermatology, Dr. Craig Zeiring.
Biologix Hair Inc (OTCQB:BLGX, OTCBB:BLGX) announced that it has created a Medical Advisory Board and has appointed past president of the American Osteopathic College of Dermatology, Dr. Craig Zeiring.
As quoted in the press release:
Dr. Ziering is certified by both the American Board of Hair Restoration Surgery and the American Osteopathic Board of Dermatology and is known in Hollywood as “The Hair Restoration Surgeon to the Stars.
Click here to read the full Biologix Hair Inc (OTCQB:BLGX, OTCBB:BLGX) press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â